Vedolizumab and Ustekinumab drugs
| Authority | Manx Care |
|---|---|
| Date received | 2022-07-27 |
| Outcome | All information sent |
| Outcome date | 2022-08-08 |
| Case ID | 2552145 |
Summary
A request was made to Manx Care for the specific number of patients receiving Vedolizumab and Ustekinumab drugs in the Isle of Man. The authority disclosed that between January and July 2022, 26 patients were associated with Ustekinumab and 6 patients received Vedolizumab treatment.
Key Facts
- The request was received on 27 July 2022 and responded to on 8 August 2022.
- The data covers the period from 1 January to 31 July 2022.
- 26 patients were recorded for Ustekinumab, with 24 having treatment dispensed.
- 6 patients had Vedolizumab treatment dispensed.
- The response included details on treatments issued and returned for Ustekinumab.
Data Disclosed
- 26 patients
- 24 had treatment dispensed
- 1 had a treatment issued and returned
- 1 had no treatments issued
- 6 patients
- 1st January
- 31st July
- 27th July 2022
- 8 August 2022
- 2552145
Original Request
For Vedolizumab and Ustekinumab drugs: I would like to know the specific number of patients who are receiving each of these drugs in the IOM. Whether it be by infusions or injections.
Data Tables (1)
Data Tables (reformatted)
| Drug | Total Patients | Treatment Dispensed | Treatment Issued and Returned | No Treatment Issued (Previous Period Returned) |
|---|---|---|---|---|
| Ustekinumab | 26 | 24 | 1 | 1 |
| Vedolizumab | 6 | 6 | - | - |
Full Response Text
Manx Care Noble’s Hospital, Strang Braddan, Isle of Man IM4 4R (01624) 650 000
Our ref: 2552145 8 August 2022
Dear ###
We write further to your request which was received on 27th July 2022 which states:
"For Vedolizumab and Ustekinumab drugs: I would like to know the specific number of patients who are receiving each of these drugs in the IOM. Whether it be by infusions or injections."
Our Response For the period between 1st January and 31st July there were: Ustekinumab: 26 patients: 24 had treatment dispensed, 1 had a treatment issued and returned, 1 had no treatments issued and a treatment from a previous period returned. Vedolizumab: 6 patients had treatment dispensed.
Please quote the reference number 2552145 in any future communications.
Your right to request a review
If you are unhappy with this response to your freedom of information request, you may ask us to carry out an internal review of the response, by completing a complaint form and submitting it electronically or by delivery/post.
An electronic version of our complaint form can be found by going to our website at https://services.gov.im/freedom-of-information/Review . If you would like a paper version of our complaint form to be sent to you by post, please contact me and I will be happy to arrange for this. Your review request should explain why you are dissatisfied with this response, and should be made as soon as practicable. We will respond as soon as the review has been concluded.
If you are not satisfied with the result of the review, you then have the right to appeal to the
Information Commissioner for a decision on;
1. Whether we have responded to your request for information in accordance with Part
2 of the Freedom of Information Act 2015; or
2. Whether we are justified in refusing to give you the information requested.
In response to an application for review, the Information Commissioner may, at any time,
attempt to resolve a matter by negotiation, conciliation, mediation or another form of
alternative dispute resolution and will have regard to any outcome of this in making any
subsequent decision.
More detailed information on your right to a review can be found on the Information Commissioner’s website at www.inforights.im. Should you have any queries concerning this letter, please do not hesitate to contact me. Further information about freedom of information requests can be found at www.gov.im/foi.
I will now close your request as of this date.